Pharmaceutical wastewater treatment using membrane bioreactor-ozonation system

The aim of this study was to evaluate the potential use of ozonation with pharmaceutical compounds on membrane bioreactor (MBR). The result has shown that high concentrations of pharmaceutical contaminants have caused destruction of cell wall, thereby reducing mixed liquor suspended solids (MLSS). It also resulted in high amounts of biopolymers in the presence of non-biodegradable pharmaceutical compound in MBR. As a result, biological removal decreased and membrane fouling happened. Ozonation treatment reached a chemical Oxygen Demand (COD) removal of 99.9% and caused better effluent quality. The MBR-ozonation process could achieve an acetaminophen and fluoxetine removal of around 98.4 and 57.83%, respectively.